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ABSTRACT
Objective: The focus of this study was to explore the nuance strategy to combat the virulence factors of the pathogens by probiotic Enterococcus 
durans LAB38.
Methods: Probiotic attributes was determined by bile salt tolerance (0.5%) and Artemia gnotobiotic assay. Quorum sensing (QS) inhibitory activity of 
the supernatant and ethyl acetate (EA) extract of LAB38 was evaluated using the indicator strains, includes Chromobacterium violaceum CV026 (mini-
Tn5 mutant of ATCC 31532), methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa (PA). Reporter strains, Vibrio harveyi 
BB170 (luxN mutant), BB886 (luxP mutant) and Escherichia coli pSB401 (pACYC184-derived) were used for bioluminescence-based target specificity 
analysis. Gas chromatography-mass spectrometry (GC-MS) analysis of EA extract was performed using standard protocol.
Results: LAB38 has shown bile salt tolerance and positive probiotic effect toward Artemia salina. In addition, 100 µg/ml EA extract has significantly 
reduced the violacein production (37±1.4%) in CV026, biofilm formation in MRSA (94±0.9 %) and PA (22±0.08%). Further, 200 µg/ml of EA extract 
has shown inhibition against both autoinducer-1 (AI-1) and AI-2 mediated QS system. Bioluminescence inhibition is directly proportional to the time 
of exposure. GC-MS result revealed that bromine, sulfur containing molecule and azulene derivative were found in the EA extract.
Conclusion: This is the first report on probiotic E. durans for quorum quenching activity. Hence, the bacterium could be used for future therapeutics 
application.
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INTRODUCTION
Biofilm is a matrix of extra polymeric substances often exerted by a 
bacterial community to protect themselves from external factors such as 
antibiotics and host defenses, consequently turned as a barrier against 
killing factors [1]. Notably, 80% of the bacterial infections are facilitated 
by biofilm [2]. Biofilm formation is relied on quorum sensing (QS) 
process, where gene expression is mediated by extracellular signaling 
molecules called autoinducers (AIs) upon population density [3]. QS 
process also plays a key role in the expression of virulence factors [4] 
and antibiotic production [5].
Human gastrointestinal tract is a suitable place for horizontal gene 
transfer from a diverse group of pathogens, making non-pathogens as 
virulent ones [6]. Methicillin resistant Staphylococcus aureus (MRSA) 
emerged as a commonly reported pathogen in the gastrointestinal 
tract [7]. Astonishingly, 96% of S. aureus causes biofilm-associated 
infections [8]. However, biofilm-assisted chronic infections of S. aureus 
are difficult to treat due to its fractious nature [9]. Similarly, it has been 
repeatedly observed that Pseudomonas aeruginosa (PA) colonize in the 
intestinal tract of the hospitalized and immunosuppressed patients [10]. 
Besides, PA causes chronic respiratory disease and prolonged chronic 
rhinosinusitis [11]. Obviously, virulence factors of PA, regulated by QS 
network are involved in the pathogenesis [12].
Hence, the inhibition of QS became an important target to attenuate 
pathogenesis, since resistance to antibiotics among pathogens is 
increasing rapidly and posing a major global threat. Although the 
pathogens are killed by antimicrobials in a host, their determinants of 
virulence may persist to harm [13]. Thus, the inhibition of QS network 
would be a productive alternate way, as it impedes the virulence gene 
expression without disturbing its growth [14]. Furthermore, it is very 
interesting to note that QS inhibition enhances the impairment of 
bacterial biofilm, thereby ease the antibiotic treatment [15].
Ample of reports are found to demonstrate the probiotics potentials of 
Enterococcus spp. For instance, intestinal tract of mammals is frequently 
colonized with Enterococcus sp., for the beneficial effects [16]. Probiotics 
with quorum quenching potential would be a unique dual strategy 
to control antibiotic-resistant pathogens and to support the host in a 
positive manner. At the best of our knowledge, there is no report on 
quorum quenching potential of the probiotic Enterococcus durans. 
Hence, the aim of this work is (i) to study the probiotic attributes and 
quorum quenching potential of E. durans LAB38 and (ii) to determine 
the spectrum of quorum quenching activity.
METHODS
Bacterial strains and culture condition
Unpasteurized cow’s milk sample was serially diluted in 0.9% saline 
and plated on de Man, Rogosa and Sharpe (MRS) agar for 48 hrs at 30°C. 
For experimental purposes, the isolate LAB38 was cultured in Luria-
Bertani (LB) medium with 2% glucose (w/v). Indicator organisms 
such as PA (ATCC 27853) and clinical isolate MRSA were cultured in 
LB medium. Chromobacterium violaceum CV026 and Escherichia coli 
pSB401 were maintained in LB medium with respective antibiotics. 
Vibrio harveyi BB170 and BB886 mutant strains were routinely 
subcultured in Luria Marine agar, and AI bioassay medium was used 
for the experimental purpose [17]. Identification of the bacterium was 
done based on the biochemical and molecular characteristics. Universal 
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primers 27F and 1492R were used for 16S rRNA gene amplification. 
Purified amplicon product was sequenced and analyzed using NCBI 
nucleotide database, and phylogenetic tree was constructed with highly 
resembled sequences using MEGA 5.03.
Probiotic attributes
Bile salt tolerance
To confirm the bile salt tolerance, the method described earlier was 
adopted [18]. Briefly, bacterial pellet was adjusted to 0.1 optical density 
(OD) using phosphate-buffered saline and it was incubated with or 
without 0.5% bile salts for 2 hrs. Survival of the bacterium was checked 
by plating 100 µl of inoculum from the respective tubes on MRS agar 
plate. After 48 hrs of incubation, viable colonies were enumerated.
Artemia gnotobiotic assay
Artemia salina cysts were cultivated routinely in 3.2% filtered and 
autoclaved saline water (FASW). Decapsulation of cysts was performed 
as described earlier [19]. Decapsulated axenic Artemia was transferred 
to the tube containing 10 ml of aerated FASW, and then probiotic 
inoculum (LAB38) was added to reach the final concentration of 0.1 OD. 
Nannochloropsis sp. was given as a feed at 25 × 103 cells per nauplii. 
The tubes containing Artemia without bacterial inoculum were used as 
control. All the tubes were kept under shaking condition for 24 hrs with 
constant incandescent light. All the experiments were done in axenic 
conditions and were performed in triplicates.
Quorum quenching assay
Cell-free supernatant of LAB38 was extracted with half volume of 
hexane and subsequently with half volume of ethyl acetate (EA) [20]. 
Extracts were concentrated using Buchi Rotavapor R-210, which 
were then stored in pre-weighed tubes. Hexane and EA extracts were 
dissolved in dimethylsulfoxide (DMSO) to make 100 mg/ml stock 
solution. Sterile DMSO was used as a control in all experiments to check 
the solvent effect on QS inhibition.
CV026 plate assay
Preliminary screening of QS inhibition was determined using 
C. violaceum CV026 (mini Tn5 mutant of C. violaceum ATCC 
31532, Kmr) [21]. LB soft agar containing 0.1 OD of CV026 inoculum 
and 1 µg/ml of C6-HSL (Sigma-Aldrich, USA), was poured over the 
molten LB hard agar. After solidification, 10 µl of filter-sterilized 
supernatant of the LAB38 was placed and incubated for 48 hrs at 30°C. 
LB medium and cinnamaldehyde (Himedia, India) were used as the 
negative and positive control, respectively.
Pigment quantification assay
Violacein pigment quantification was performed as described 
previously [22] with some modification. A volume of 500 µl inoculum 
consist of CV026 and C-6-HSL (1 µg/ml) was added to each well in 
a 24-well microtitre plate. Hexane and EA extract were added at a 
concentration of 100 µg/ml. Then, the extract containing inoculum was 
serially diluted with fresh inoculum by half-dilution technique. After 24 
hrs, pigment extraction was done from bacterial pellet using 1 ml of 
DMSO. After a brief vortex, cell-free pigment extract was measured at 
585 nm. CV026 without compound was acts as a control. To confirm the 
exclusive quorum quenching inhibition (independent from cell growth) 
of the extract, cell density of CV026 was measured at 600 nm using 
ultraviolet visible spectrophotometer (Elico SL-159). The following 
formula was used to calculate the percentage of inhibition:
(DMSO control  OD Compounded  treated  OD)







Pyocyanin of Pseudomonas spp. plays a key role in pathogenesis. It 
was quantified as described elsewhere [23]. Briefly, 0.1 OD adjusted 
inoculum of PA was incubated for 48 hrs with or without 50 µg/ml of EA 
extract. Then, the supernatant was extracted with 3 ml of chloroform 
followed by vortex for few seconds. Chloroform layer was separated and 
transferred to a new tube along with 1 ml of 0.2 M HCl. After a gentle 
mixing, all tubes were centrifuged and pink color layer was measured 
at 520 nm.
Biofilm inhibition assay
Biofilm inhibition was done by static ring tube assay with filter-
sterilized supernatant of LAB38. Biofilm inhibition was quantitatively 
determined (microdilution method) using polystyrene 96-well U 
bottom plate [24]. Briefly, indicator organisms such as MRSA and PA 
were adjusted to 0.1 OD, respectively, and 200 µl of inoculum was 
added to each well. EA extract of LAB38 was added into the well at a 
concentration of 100 µg/ml. Then, it was subsequently serial diluted 
for four times to the next well to make half the concentration of the 
extract. After 36 hrs of static incubation, planktonic cells and non-
adhered cells were removed by washing the well with 0.9% saline 
thrice. In each well, 0.1% w/v of crystal violet was added and left 
for 20 minutes. Then, crystal violet was discarded, and the well was 
washed with de-ionized water to remove excess crystal violet. After 
2 minutes of air drying, 33% acetic acid was used to dissolve crystal 
violet, and the absorbance was measured at 570 nm using enzyme-
linked immunosorbent assay reader (Bio-Rad Model 680). To confirm 
the quorum quenching effect (independent of cell density) of the EA 
extract against MRSA and PA, protocol was followed as mentioned in 
pigment quantification assay, where incubation was kept in shaking 
condition. Percentage of  growth inhibition was calculated as described 
for violacein inhibition.
Bioluminescence-based target analysis
Target specificity analysis was performed according to the previously 
described protocol [25] with little modification. Briefly, V. harveyi 
reporter strains, BB170and BB886 were grown for 18 hrs and diluted 
in fresh AI bioassay medium in the ratio of 5:100, respectively. Then, 
200 µg/ml of EA extract was added and incubated at 28°C. As far as 
E. coli pSB401 is concerned, 0.1 OD of inoculum supplemented with 
3-oxo-C-6-HSL (50 µg/ml) was used. Luminescence reading was 
measured at 30 minutes, 1 hr and 3 hrs. All the luminescence readings 
were recorded using Modulus multimode reader (Turner Biosystem) 
and expressed in relative light units.
Gas chromatography-mass spectrometry (GC-MS) analysis
GC-MS analysis was performed on Thermo GC-Trace Ultra Version 
5.0, equipped with DB 5-MS capillary standard non-polar column 
(30 Mts × 0.25 mm ID × 0.25 μm film). Helium was used as the carrier 
gas with a flow rate of 1 ml/minute. GC oven temperature was initiated 
at 70°C and increased at a rate of 6°C/minute to 260°C. 1 µl of the EA 
extract was injected and run for 37.51 minutes in 1:10 split ratio. GC-
MS peaks were analyzed by the relative abundance of the compounds 
from each retention time. Peaks were matched with the database of the 
National Institute of Standard and Technology (http://www.sisweb.
com/software/ms/nist.htm).
RESULTS AND DISCUSSION
This study is an initiative to explore pharmaceutical and commercial 
importance bacterium, which has exhibited probiotics’ attributes 
and quorum quenching activity. Biochemical and molecular 
characteristics revealed that the isolate LAB38 belongs to the 
genera Enterococcus sp. The sequence was submitted to GenBank 
database and accession no. (KJ720654) was obtained. Phylogenetic 
analysis revealed that the sequence of LAB38 is highly matched with 
the sequence of existing probiotic strains. E. durans is a potential 
probiotic, which additionally produces antimicrobials to defend against 
pathogens [26]. Although probiotic E. durans has been reported to 
produce the antimicrobial peptide, this is the first report for quorum 
quenching activity, isolated from unpasteurized milk. However, many 
reports are endorsed the concept of quorum quenching activity in 
probiotics [27,28].
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Probiotic attributes
Tolerance to bile salts is an inevitable credential for probiotics, as 
bile salts reduce bacterial survival in the intestine by impairing 
its cell membrane [29]. Viable colony of LAB38 was found about 
4.5 × 103 CFU/ml in treated and 5.5 × 103 CFU/ml in the control media. 
Although bile salt delayed the growth of LAB38, the bacterium has 
survived successfully in the bile environment. Evidently, many reports 
are found to describe the bile salt tolerance of Enterococcus spp. [30]. 
Artemia is an excellent model organism to study the impact of probiotic 
bacteria on its survival and development [31]. Artemia has shown 
100% survival in both control and LAB38-treated medium. It clearly 
indicated that the tested LAB38 has not exhibited any pathogenic effect 
on Artemia nauplii. In the presence of LAB38, 5.7±0.5% µm of length 
has increased in Artemia than that of control. Moreover, the growth 
of the Artemia was promoted, in which the development of thoracic 
segments is clearly observed in the presence of live LAB38 (Fig. 1). 
Apparently, it delineated that Artemia nauplii acquired probiotic effect 
from LAB38.
Quorum quenching assay
Inhibition of QS-regulated pigment production
Violacein is a purple pigment, which is regulated by QS network. 
Zone of nonpigmented CV026 was observed as a consequence of 
the addition of supernatant. Moreover, hexane extract of LAB38 has 
shown neither antimicrobial nor quorum quenching activity, whereas 
EA extract has shown inhibitory activity on pigment production 
without disturbing the growth of CV026. In addition, EA extract 
(100 µg/ml) has shown a maximum of 37.1±1.4% inhibition against 
violacein pigment production. It was reported that Cuminum cyminum 
methanol extract (500 µg/ml) has exhibited nearly 30% inhibition 
of violacein production [32]. Remarkably, 100 µg/ml of EA extract of 
LAB38 was sufficient to show 37% inhibition of violacein production. 
Moreover, inhibition of pigment production was found even in the 
one-fourth diluted EA extract containing medium (Fig. 2a). There 
was a significant negative correlation (r2=0.8738) between inhibition 
of violacein production and the concentration of the EA extract. 
This described that the violacein production is affected in a dose-
dependent manner.
Pyocyanin is a blue phenazine redox active secondary metabolite of PA 
causes adverse invasive pulmonary infection by inhibiting the ciliary 
function, epidermal cell growth and prostacyclin release [33]. In the 
presence of 50 µg/ml of EA extract, 19.3±1.2% of pyocyanin production 
has inhibited. Thus, the EA extract of the potential probiotic strain has 
additional value of bearing quorum quenching activity.
Biofilm inhibition
Biofilm is a prominent virulence factor that eases the colonization 
and protects the cells from host immune system [34]. Supernatant of 
LAB38 has shown inhibition against biofilm formation of MRSA and 
PA. Furthermore, 100 µg/ml of EA extract has exhibited 94±0.9% and 
22±0.08% of inhibition against biofilm formation of MRSA and PA, 
respectively. Even one-fourth concentration of 100 µg/ml of EA extract 
has shown inhibition against biofilm of MRSA (Fig. 2b). Significant 
negative correlation (r2=0.9158) between biofilm inhibition and 
concentration of the EA extract was observed. As the biofilm of PA 
received moderate inhibition, further dilutions were not made to check 
the biofilm inhibitory concentration. The ratio of biofilm formation and 
plantonic cells (OD570/600) clearly indicates that biofilm density of 
MRSA was significantly reduced (p<0.0001) in EA extract treated sample 
(0.318±0.007), compared to DMSO control (5.379±0.149) . Moreover, 
cell density was unaffected by the extract, whereas adherence was 
significantly reduced. Many studies reported that intestinally colonized 
MRSA spread to the skin surfaces to facilitate the transmission 
vigorously [35]. Colonization of S. aureus in the intestinal tract can be 
eliminated by probiotic lactic acid bacteria, which eventually kill by its 
antimicrobial substances [36]. Thus, it is proved that probiotic LAB38 
has devastated the biofilm formation of MRSA and PA.
Bioluminescence-based target analysis
Bioluminescence of V. harveyi is regulated by AI-1 and AI-2 type of 
signaling molecules [25]. V. harveyi BB170 can respond only to AI-2 
type of signaling molecule, as it is sensor 1− sensor 2+, whereas BB886 
is sensor 1+ sensor 2−, so it can respond to AI-1 type of signaling 
molecules [37]. In this study, 200 µg/ml of EA extract has started to 
show 14.8±4.8% of bioluminescence inhibition in BB170 after 1 hr 
incubation. Increased trend of bioluminescence inhibition (53.7±0.3%) 
has exhibited after 3 hrs of incubation (Fig. 3a). Similarly, the same 
trend of inhibition was found in BB886. After 3 hrs of incubation, 
60±1.8% of bioluminescence inhibition was observed in V. harveyi 
BB886 in the presence of 200 µg/ml of EA extract (Fig. 3b). There 
was no reduction in bioluminescence at 30 minutes in both BB170 
and BB886. There was a significant positive correlation (r2=0.8676) 
between bioluminescence inhibition and increasing incubation time 
in BB170. Similarly, a significant correlation (r2=0.7902) was found in 
the reporter BB886 as well. Based on the results obtained from these 
two reporters in response to time of incubation, it is revealed that the 
inhibition of both QS systems (AI-1 and AI-2) is directly proportional 
to the time of exposure. In support of this results, it was reported that 
AI-2 is involved in the biofilm formation and virulent gene expression 
of Staphylococci [38].
E. coli pSB401 (pACYC184-derived, Tetr) is an AHL based biosensor, 
which can produce bioluminescence in the presence of 3-oxo-
Fig. 1: Artemia gnotobiotic assay. After 24 hrs of incubation, 
LAB38 treated Artemia (T) has promoted to the next stage of 
growth than that of control (C)
Fig. 2: (a) Inhibition of violacein pigment production by ethyl 
acetate (EA) extract of LAB38 (n=3). Pigment was estimated 
spectrophotometrically at 585 nm. Bar 1 represents the 
inhibition of violacein production by full strength (100 µg/mL) 
of EA extract. Subsequent bars represent the inhibition 
of pigment production by half strength of the proceeding 
concentration. (b) Inhibition of methicillin resistant 
Staphylococcus aureus (MRSA) biofilm by EA extract of LAB38 
(n=3). Bar 1 indicates the inhibition of MRSA biofilm by full 
strength (100 µg/ml) of LAB38 EA extract. Adjacent bars 
represent the inhibition of MRSA biofilm by half strength of the 
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C6-HSL [39]. There was no significant bioluminescence inhibition 
found in the reporter strain pSB401 (only around 10% of inhibition 
was found at all incubation time intervals). Furthermore, there 
was no significant (r2=0.1692) correlation between inhibition of 
bioluminescence and increasing time intervals (Fig. 4). It implied that 
the extract has not interfered in luxR sensor-based bioluminescence. 
Obviously, the result delineated that EA extract is unable to quench 
3-oxo-C6-HSL signaling molecule or interferes with the receptors of 
this molecule. In conclusion, from the present work, the EA extract of 
LAB38 has not exhibited antimicrobial activity against any of the tested 
strains, which apparently expounded that the inhibition merely was on 
QS network. Perhaps, EA extract was involved in either the process of 
inactivating signaling molecules/receptor proteins or competing for 
the receptor proteins. However, further studies are required to confirm 
the speculation.
GC-MS analysis
GC-MS chromatogram revealed about 30 types of different compounds 
in EA extract. Indeed, five compounds has existed with high percentage 
of probability, in which four compounds occupied almost 50% of the 
total extract. Furthermore, those four peaks at the retention time 
11.87, 14.13, 19.69, and 12.86 were not matched with the commercial 
database, revealing the novelty of the compounds (Table 1). Based 
on the relative abundance, it was speculated that 7,9-di-tert-butyl-
1-oxaspiro (4,5) deca-6,9-diene-2,8-dione is possibly involved in 
QS inhibition activity. This compound was an azulene derivative. 
Moreover, it has not matched with the existing compound databases, 
which designated the compound as novel. However, some of the 
metabolites of the extract have been previously reported for biofilm 
inhibition. Bromine-containing furanones are potential inhibitors 
of biofilm of several pathogens [40]. Sulfur atom plays a role in 
biofilm inhibition [41]. Though many QS inhibitors were ascertained 
from various biological resources [42-44] this study highlighted the 
significance of the bacterial source especially E. durans and its possible 
quorum quenching mechanisms.
Fig. 4: Bioluminescence inhibition by ethyl  acetate extract (n=3) 
against luxR based reporter strain pSB401
Table 1: GC MS analysis of ethyl acetate extract 
Retention 
time
Compound name p Relative 
abundance
7.2 Acetic acid, 2-propenyl ester (CAS) 21.99 0.54
7.83 1-butanol (CAS) 12.67 0.75
10.16 Isobutyric acid-2-d1 41.00 6.62
12.08 l-alanine, N-propoxycarbonyl-, dodecyl ester 54.26 0.34
17.65 E-15-heptadecenal 9.69 0.48
18.7 Tetradecanoic acid (CAS) 84.65 2.97
19.32 (E)-2-(2H (1)-4-methoxyphenylethene 13.03 0.45
19.72 (E)-2-(2H (1)-4-methoxyphenylethene 18.01 1.32
21.76 1-octadecene (CAS) 8.54 2.75
22.93 Hexadecanoic acid 78.74 5.82
23.09 2-(dimethylhydrazono) butanal 63.86 2.27
23.84 7,9-di-tert-butyl-1-oxaspiro (4,5) deca-6,9-diene-2,8-dione 92.34 0.97
24.98 2,6-dibromo-3-pyridinyl 3-methyl-2-butenyl ether 16.64 11.87
25.55 1-docosanol, methyl ether 5.58 3.42
26.85 (erythro)-5-methyl-2-phenylsulphonylhexan-3-ol 36.65 14.13
27.18 1à,5à,9,12,12-pentamethyl-4,8-dioxo-15á-cetyloxy-11à,13à-tetracyclo[8.5.0.0 (3,7).0 (11,13)]pentace-9-ene 29.58 19.69
27.40 1-methyl-3-(methylamino)-4-pyrazolecarboxamide 20.85 0.92
28.34 2-(n-butylidene)6-n-butylcyclohexanone 28.98 1.76
28.94 5-(N-methylanilino)-4-(N-methyl-N-phenylcarbamoyl)-2,3-dioxo-2,3-dihydrofuran 62.29 1.90
30.26 Cyclohexane, 1,3,5-trimethyl-2-octadecyl (CAS) 53.09 0.89
31.38 n-tetracosanol-1 7.92 1.38
32.46 2-benzyl-3,6-dioxo-5-isopropylpiperazine 94.02 0.44
32.71 2-nonadecanone 9.07 0.31
33.14 Di-(2-ethylhexyl) phthalate 21.28 1.31
33.79 Cyclo-(l-leucyl-l-phenylalanyl) 82.27 0.37
34.42 Octacosyl trifluoroacetate 3.92 0.78
34.75 4-(3-hydroxypropynyl)-3-(2-nitroethyl)indole 69.08 1.83
35.52 1-acetyl-4-methyl-1,3-dihydropyrrole-2,2-dicarboxylic acid, diethyl ester 7.13 12.86
36.23 Diethyl 2-methylphenyl(methylthio)methanephosphonate 46.11 0.29
39.11 Hexatriacontyl pentafluoropropionate 3.14 0.58
Total 100.1
GC-MS: Gas chromatography-mass spectrometry, P: Probability
Fig. 3: (a and b) Represent the effect of ethyl acetate (EA) extract 
on inhibition of bioluminescence against Vibrio harveyi BB170 
and V. harveyi BB886, respectively. Bioluminescence-based 
target analysis was evaluated at different incubation time with 
200 µg/ml of EA extract of LAB38 (n=3)
ba
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CONCLUSION
In this comprehensive study, the probiotic E. durans showed immense 
potential to curb the pathogenesis in terms of quorum quenching. 
Indeed, it has the potential to inhibit the biofilm of MRSA and PA. The 
results implied that the extract has the inhibitory activity against both 
AI-1 and AI-2 mediated QS systems. Furthermore, a broad range of QS 
inhibition was explored with clear evidence using reporter strains such 
as C. violaceum CV026, E. coli pSB401, V. harveyi BB170 and BB886. It 
was speculated that the key azulene derivative might be involved in the 
quorum quenching mechanism, as the molecule was relatively abundant 
in the extract, but confirmation and its mechanisms of activity remain 
to be elucidated. Our results suggested that LAB38 has commercial 
value, as it has both probiotic and quorum quenching attributes.
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